IT
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
de|fr|it|en
Basilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion ZurigoBasilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion Zurigo
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Dr. Nicolas Mosimann
  • Kellerhals Carrard advises on the sale of a majority stake in Hipp Technology GroupKellerhals Carrard advises on the sale of a majority stake in Hipp Technology Group24 marzo 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors11 marzo 2026
  • Deal Ticker: Kellerhals Carrard advised on the sale of LakeraDeal Ticker: Kellerhals Carrard advised on the sale of Lakera6 novembre 2025
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics15 maggio 2025
  • Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.4 aprile 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma3 dicembre 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG27 maggio 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.23 agosto 2023
  • Deal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker CorporationDeal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker Corporation6 gennaio 2023
  • Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.19 dicembre 2022
  • MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.6 aprile 2022
  • Deal-Ticker: Swiss entrepreneurial group led by Kontivia acquires majority stake in Katadyn GroupDeal-Ticker: Swiss entrepreneurial group led by Kontivia acquires majority stake in Katadyn Group13 ottobre 2021